CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20220143037A1
SERIAL NO

17586228

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SPRUCE BIOSCIENCES INC611 GATEWAY BOULEVARD SUITE #740 SOUTH SAN FRANCISCO CA 94080

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
GERBER, Hal San Francisco, US 14 82
HOWERTON, Alexis San Francisco, US 14 82
HUANG, Michael San Francisco, US 62 1596

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation